US Stock MarketDetailed Quotes

CSBR Champions Oncology

Watchlist
  • 6.330
  • +1.170+22.67%
Close Dec 13 16:00 ET
  • 6.300
  • -0.030-0.47%
Post 20:01 ET
86.05MMarket Cap-126.60P/E (TTM)

Champions Oncology Key Stats

Champions Oncology Q2 2025 Earnings Date

Currency:USDDec 11, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
13.05M
13.49M
+435.00K
Beat Est.
+12.80%
+16.56%
+3.33%
EPS
--
0.05
--
+133.33%
Buy

Dec 12, 2024

Champions Oncology Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 15.667M--
--2025/Q3-- / 12.932M--
Dec 11, 20242025/Q213.489M / 13.054M--
Sep 11, 20242025/Q114.061M / 13.227M--
--2024/Q414.001M / 12.692M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q4-- / 15.667M--
--2025/Q3-- / 12.932M--
Dec 11, 20242025/Q213.489M / 13.054M--
Sep 11, 20242025/Q114.061M / 13.227M--
--2024/Q414.001M / 12.692M--

Unlock Free Earnings Estimates

Champions Oncology Earnings Reports

Read more

Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Analysis

Analyst Rating

Updated: Dec 12, 2024

Buy

  • Buy

    100.00%
  • Hold

    0.00%
  • Sell

    0.00%

Price Target

No Data